Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
Recruiting now
Conditions studied: Plasma Cell Disorders
In brief
A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders
Key facts
- Study ID
- NCT06252948
- Run by
- Mayo Clinic
- People needed
- 240
- Starts
- 2021-12-29
- Expected to finish
- 2028-12-29
- Last updated by the study team
- 2026-02-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Diagnosed with POEMS syndrome (newly diagnosed or in remission) or with newly diagnosed multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), amyloid light chain (AL) amyloidosis or healthy controls from their households
You may not qualify if…
- Age under 18 years
- Pregnancy
- Substance abuse
- Antibiotics use or gastrointestinal endoscopy in the 3 months prior to the study participation
- Chronic gastrointestinal disorder
- Gastrointestinal surgeries in the past 2 years
- Chemotherapy (including anti-plasma cell treatment and steroids) or radiation treatment for cancer within the last 2 years or active cancer (other than plasma cell disorder)
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.